Type 1 diabetes (T1D) is an autoimmune disease that affects more than 3 million Americans. It is characterized by the infiltration and destruction of beta cells in the pancreatic islets of Langerhans by CD4+ and CD8+ T cells. Recent work from our labs has also demonstrated that CD8?+ dendritic cells are essential for the initiation of T1D. These cells are normally responsible for cross-presentation of extracellular antigens in order to activate a cytotoxic T cell response against intracellular pathogens. CD8?+ dendritic cells may, however, also inappropriately cross-present self-antigens, such as from pancreatic beta cells, in order to initiate a CD8+ T cell response against normal host tissues. This inadvertent function may explain why they are necessary for the initiation of T1D. Determining the mechanisms of cross-presentation and its role in autoimmunity may therefore provide vital clues into the pathogenesis of T1D, and may also hasten the development of therapeutic measures to prevent its onset. In this proposal, we will identify the mechanisms by which cross-presentation occurs and the role it plays in T1D. In order to investigate these questions, we have generated novel Rab43 knockout mice. CD8?+ dendritic cells from these mice exhibit deficient in vitro and in vivo cross-presentation.
In Aim 1, we will identify the intracellular vesicular pathways to which Rab43 directs antigen for cross-presentation. We will also determine what extracellular receptors recruit Rab43 to phagosomes in order to cross-present their contents.
In Aim 2, we will determine whether deficient cross-presentation impacts the development of T1D. We will use the non-obese diabetic (NOD) mouse strain as a model of T1D, as it recapitulates many features of the human disease including the spontaneous destruction of islet beta cells. We will backcross the Rab43 knockout allele onto the NOD background in order to produce the NOD.Rab43-/- strain, which will exhibit deficient cross- presentation on a background of susceptibility to diabetes. We will characterize whether these mice are resistant to the development of hyperglycemia and the destruction of islet beta cells. We will further analyze whether this strain has a selective deficiency in activating the autoreactive CD8+ T cells that mediate the destruction of beta cells. Together, the findings generated from this proposal should determine whether cross- presentation plays a role in the pathogenesis of T1D, and, if so, will also identify the pathways whose therapeutic modulation could prevent the initiation of the autoimmune response.
Type 1 diabetes (T1D) is an autoimmune disease that affects over 3 million Americans. Critical to its pathogenesis are CD8?+ dendritic cells, which may be necessary because they inappropriately cross-present self-antigens to induce a cytotoxic CD8+ T cell response against normal pancreatic beta cells. We intend to study the mechanisms of cross-presentation and its role in initiating the autoimmune response that results in T1D.
| Theisen, Derek J; Davidson 4th, Jesse T; Briseño, Carlos G et al. (2018) WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science 362:694-699 |
| Briseño, Carlos G; Satpathy, Ansuman T; Davidson 4th, Jesse T et al. (2018) Notch2-dependent DC2s mediate splenic germinal center responses. Proc Natl Acad Sci U S A 115:10726-10731 |
| Durai, Vivek; Bagadia, Prachi; Briseño, Carlos G et al. (2018) Altered compensatory cytokine signaling underlies the discrepancy between Flt3-/- and Flt3l-/- mice. J Exp Med 215:1417-1435 |
| Iwata, Arifumi; Durai, Vivek; Tussiwand, Roxane et al. (2017) Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF-IRF4 transcription factor complex. Nat Immunol 18:563-572 |
| Briseño, Carlos G; Gargaro, Marco; Durai, Vivek et al. (2017) Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. Proc Natl Acad Sci U S A 114:3957-3962 |
| Durai, Vivek; Murphy, Kenneth M (2016) Functions of Murine Dendritic Cells. Immunity 45:719-736 |
| Briseño, Carlos G; Haldar, Malay; Kretzer, Nicole M et al. (2016) Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells. Cell Rep 15:2462-74 |
| Kretzer, Nicole M; Theisen, Derek J; Tussiwand, Roxane et al. (2016) RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med 213:2871-2883 |
| Wu, Xiaodi; Briseño, Carlos G; Durai, Vivek et al. (2016) Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells. J Exp Med 213:2553-2565 |
| Murphy, Theresa L; Grajales-Reyes, Gary E; Wu, Xiaodi et al. (2016) Transcriptional Control of Dendritic Cell Development. Annu Rev Immunol 34:93-119 |
